Contemporary Management of HIV: First-line and Switch Strategies Using Current ART Regimens

Download this expert-authored slideset to review national guidelines, key study data, and individual considerations for optimizing the use of current ART regimens as initial HIV treatment and in switch strategies for patients with viral suppression who require a change in therapy.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Babafemi Taiwo, MBBS
Format: Microsoft PowerPoint (.ppt)
File Size: 531 KB
Released: July 6, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Related Content

Clinical Care Options (CCO): patient perspective on the decision to switch to long-acting injectable ART and the impact it has had on her life.

person default Anonymous Patient Released: September 16, 2021

Dr Milena Murray and Clinical Care Options (CCO): Current pharmacokinetic and safety data support the use of tenofovir alafenamide during pregnancy

person default Milena Murray, PharmD, MSc, BCIDP, AAHIVP Released: September 15, 2021

Clinical Care Options (CCO) faculty Dr David Malebranche’s expert commentary on racial disparities in HIV care and strategies for improving patient engagement

David Malebranche, MD, MPH Released: September 15, 2021

Download CCO slides reviewing clinically relevant new data reported at IAS 2021 on a wide range of ART management topics.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Daniel R. Kuritzkes, MD
Released: September 13, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue